Purple Biotech (PPBT) Competitors $3.54 0.00 (0.00%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends PPBT vs. MIRA, GOVX, CYTH, APRE, CARM, BFRG, BTAI, PIRS, AFMD, and MEIPShould you be buying Purple Biotech stock or one of its competitors? The main competitors of Purple Biotech include MIRA Pharmaceuticals (MIRA), GeoVax Labs (GOVX), Cyclo Therapeutics (CYTH), Aprea Therapeutics (APRE), Carisma Therapeutics (CARM), Bullfrog AI (BFRG), BioXcel Therapeutics (BTAI), Pieris Pharmaceuticals (PIRS), Affimed (AFMD), and MEI Pharma (MEIP). These companies are all part of the "pharmaceutical products" industry. Purple Biotech vs. MIRA Pharmaceuticals GeoVax Labs Cyclo Therapeutics Aprea Therapeutics Carisma Therapeutics Bullfrog AI BioXcel Therapeutics Pieris Pharmaceuticals Affimed MEI Pharma Purple Biotech (NASDAQ:PPBT) and MIRA Pharmaceuticals (NASDAQ:MIRA) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their risk, earnings, community ranking, media sentiment, profitability, dividends, valuation, analyst recommendations and institutional ownership. Does the MarketBeat Community favor PPBT or MIRA? Purple Biotech received 14 more outperform votes than MIRA Pharmaceuticals when rated by MarketBeat users. However, 100.00% of users gave MIRA Pharmaceuticals an outperform vote while only 94.44% of users gave Purple Biotech an outperform vote. CompanyUnderperformOutperformPurple BiotechOutperform Votes1794.44% Underperform Votes15.56%MIRA PharmaceuticalsOutperform Votes3100.00% Underperform VotesNo Votes Is PPBT or MIRA more profitable? Purple Biotech's return on equity of -55.86% beat MIRA Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Purple BiotechN/A -55.86% -44.67% MIRA Pharmaceuticals N/A -337.44%-280.58% Do analysts rate PPBT or MIRA? Purple Biotech currently has a consensus target price of $33.00, indicating a potential upside of 832.20%. MIRA Pharmaceuticals has a consensus target price of $14.00, indicating a potential upside of 1,096.58%. Given MIRA Pharmaceuticals' stronger consensus rating and higher probable upside, analysts plainly believe MIRA Pharmaceuticals is more favorable than Purple Biotech.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Purple Biotech 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00MIRA Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.33 Does the media prefer PPBT or MIRA? In the previous week, MIRA Pharmaceuticals had 1 more articles in the media than Purple Biotech. MarketBeat recorded 1 mentions for MIRA Pharmaceuticals and 0 mentions for Purple Biotech. MIRA Pharmaceuticals' average media sentiment score of 0.26 beat Purple Biotech's score of 0.00 indicating that MIRA Pharmaceuticals is being referred to more favorably in the news media. Company Overall Sentiment Purple Biotech Neutral MIRA Pharmaceuticals Neutral Do insiders & institutionals believe in PPBT or MIRA? 9.6% of Purple Biotech shares are held by institutional investors. Comparatively, 35.2% of MIRA Pharmaceuticals shares are held by institutional investors. 3.0% of Purple Biotech shares are held by insiders. Comparatively, 6.7% of MIRA Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Which has more volatility and risk, PPBT or MIRA? Purple Biotech has a beta of 1.01, meaning that its share price is 1% more volatile than the S&P 500. Comparatively, MIRA Pharmaceuticals has a beta of 2.12, meaning that its share price is 112% more volatile than the S&P 500. Which has higher earnings and valuation, PPBT or MIRA? MIRA Pharmaceuticals is trading at a lower price-to-earnings ratio than Purple Biotech, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPurple BiotechN/AN/A-$19.88M-$8.79-0.40MIRA PharmaceuticalsN/AN/A-$11.98M-$0.56-2.09 SummaryMIRA Pharmaceuticals beats Purple Biotech on 12 of the 16 factors compared between the two stocks. Get Purple Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for PPBT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PPBT vs. The Competition Export to ExcelMetricPurple BiotechPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$4.71M$6.58B$5.39B$9.13BDividend YieldN/A2.96%5.37%4.00%P/E Ratio-0.4010.0188.8317.53Price / SalesN/A337.621,282.53134.37Price / CashN/A22.6336.6032.90Price / Book0.135.084.964.69Net Income-$19.88M$154.90M$117.89M$224.57M7 Day Performance-2.21%2.59%2.75%3.33%1 Month Performance3.51%1.52%3.63%5.33%1 Year PerformanceN/A5.49%27.27%22.97% Purple Biotech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PPBTPurple Biotech1.3499 of 5 stars$3.54flat$33.00+832.2%N/A$4.71MN/A-0.4020MIRAMIRA Pharmaceuticals2.6989 of 5 stars$1.20-4.8%$14.00+1,066.7%+45.7%$19.87MN/A-2.142GOVXGeoVax Labs3.2982 of 5 stars$2.10-5.8%$14.20+576.2%-50.7%$19.82M$3.09M0.0010CYTHCyclo Therapeutics1.7853 of 5 stars$0.66+5.8%$0.95+44.2%-51.5%$18.96M$870,725.00-0.739Gap DownAPREAprea Therapeutics3.8237 of 5 stars$3.42-6.6%$15.50+353.2%-28.6%$18.59M$580,000.00-1.227News CoverageGap UpCARMCarisma Therapeutics3.6266 of 5 stars$0.44-6.3%$4.94+1,018.4%-80.8%$18.44M$14.92M-0.2820Short Interest ↓Gap DownBFRGBullfrog AI0.2538 of 5 stars$2.12-0.2%N/A-56.6%$18.43M$60,000.00-2.494BTAIBioXcel Therapeutics4.5484 of 5 stars$0.37-1.9%$2.81+659.9%-86.6%$18.37M$2.28M-0.1790PIRSPieris Pharmaceuticals0.6727 of 5 stars$13.60-15.7%N/A+2.0%$17.95M$42.81M-1.12140Analyst ForecastGap DownAFMDAffimed4.3063 of 5 stars$1.10-6.8%$13.50+1,127.3%-80.5%$17.79M$877,000.000.00200Positive NewsGap UpMEIPMEI Pharma4.0537 of 5 stars$2.67-1.1%$7.00+162.2%-39.3%$17.79M$65.30M-0.38100Analyst ForecastNews Coverage Related Companies and Tools Related Companies MIRA Pharmaceuticals Competitors GeoVax Labs Competitors Cyclo Therapeutics Competitors Aprea Therapeutics Competitors Carisma Therapeutics Competitors Bullfrog AI Competitors BioXcel Therapeutics Competitors Pieris Pharmaceuticals Competitors Affimed Competitors MEI Pharma Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:PPBT) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Purple Biotech Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Share Purple Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
